Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies-Reference-Cited by-同舟云学术

Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies

Published:1989-01 Issue:1 Volume:20 Page:53-57
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Noguchi Masayuki,Nakajima Takashi,Hirohashi Setsuo,Akiba Tadashi,Shimosato Yukio

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference25 articles.

1. Malignant mesothelioma. Ultrastructural distinction from adenocarcinoma;Warhol;Am J Surg Pathol,1982

2. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: An ultrastructural and cytochemical comparison;Dewar;J Pathol,1987

3. Electron microscopy in the diagnosis of pleural mesotheliomas;Wang;Cancer,1973

4. Ultrastructure of human mesotheliomas;Davis;JNCI,1974

5. Mesotheliomas. A light- and electron-microscopical study concerning histogenetic relationships between the epithelial and the mesenchymal variants;Bolen;Am J Surg Pathol,1980

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Pulmonary Collectins, Surfactant Protein A (SP-A) and Surfactant Protein D (SP-D) in Cancer;Cancers;2024-09-10

2. Lung Carcinoma;Serous Effusions;2018

3. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma;Journal of Hematology & Oncology;2016-09-29

4. Clinicopathological Features of Patients with Malignant Mesothelioma in a Multicenter, Case-Control Study: No Role for ABO-Rh Blood Groups;Asian Pacific Journal of Cancer Prevention;2013-01-31

5. Epithelial Tumours;The Ultrastructure of Human Tumours;2013